Sanofi-aventis, Glenmark Sign License Agreement
As per the terms of the agreement, Glenmark is expected to receive an upfront payment as well as development, regulatory and commercial milestone payments from Sanofi-aventis. All such
The European Commission (EC) has approved an extended use of Johnson & Johnson’s Tecvayli (teclistamab), along with daratumumab, to treat adult patients with relapsed or refractory multiple myeloma (r/r MM).
Wyatt Technology said that DynaPro facilitated the detection of aggregation in early stages of micellisation of pluronic polymeric surfactant due to temperature effects, pH, salinity concentration and composition.